Arteriocyte, Inc. Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
1/31/2013 9:21:59 AM
More...
|
National Institutes of Health (NIH) Awards Grant to Arteriocyte, Inc. and Its Collaboration With the University of Utah and Dana Farber to Develop Its NANEX™ Technology for Use in Bone Marrow Transplant
8/23/2012 10:45:16 AM
More...
|
Arteriocyte, Inc. Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
4/4/2012 9:49:58 AM
More...
|
Arteriocyte, Inc. Receives $1 Million Award From Ohio Third Frontier Program to Advance Its NANEX™ Technology Toward Clinical Use
7/20/2011 11:31:24 AM
More...
|
Arteriocyte, Inc. and the U.S. Army Institute of Surgical Research (USAISR) Sign a CRADA to Speed Development of Cellular Therapies for Orthopaedic Trauma
6/7/2011 11:28:35 AM
More...
|
Arteriocyte, Inc. Receives FDA Approval to Move Forward with Critical Limb Ischemia Trial
1/28/2011 9:19:42 AM
More...
|
Arteriocyte, Inc. Announces the Launch of NANEX(TM) Stem Cell Expansion System at the Upcoming American Society for Cell Biology Meeting
12/2/2010 11:25:46 AM
More...
|
Arteriocyte, Inc. Named Top Biotech Start Up Venture by the Ohio Venture Association for 2010
6/28/2010 9:21:25 AM
More...
|
Arteriocyte, Inc. Wins $4.99 Million in Grant Money
5/1/2009 8:12:22 AM
More...
|
Arteriocyte, Inc. Awarded Ohio Third Frontier Funding for Company's STEM-PREP and NANEX Technologies
4/30/2009 1:33:24 PM
More...
|
|